GEN Exclusives

More »

Feature Articles

More »
Jan 15, 2009 (Vol. 29, No. 2)

Enhancing PCR for Diagnostic Applications

Usage Ranges from the Functional Analysis of Genes to the Diagnosis of Disease

  • miRNA and Muscle Link

    Click Image To Enlarge +
    The nCounter Prep Station is the automated fluidic-handling component of the nCounter System. It processes samples post-hybridization to prepare them for data collection on the nCounter Digital Analyzer.

    Also presenting at the upcoming conference in Germany will be Christian Thirion, Ph.D., CSO, Sirion Biotech. Dr. Thirion’s talk will focus on “Disregulated microRNAs—Novel Therapeutic Targets in Muscular Dystrophies.”

    He notes that tumor necrosis factor alpha (TNF-α) is a prototypical inflammatory cytokine and a well-known mechanism for negating fusion in muscle cells.  The injured muscles must be regenerated by myoblasts.

    It is also well known that microRNAs are central regulators of muscle differentiation and that several cytokines might counter miRNA expression. In fact, Dr. Thirion points to 126 citations in the literature since 2005 linking miRNA and muscle. 

    Using a TaqMan low density array analysis, Dr. Thirion’s group found a number of miRNAs that were significantly upregulated and others that were significantly downregulated. When TNF-α was added, two key miRNAs in the previously upregulated group were downregulated. These were has-miR-133b and has-miR-206.

    In addition TNF-a strongly upregulated miR-155, a microRNA linked to inflammation. When Agilent’s microarray analysis was substituted for TaqMan and TNF-α was added, all four downregulated miRNAs are muscle specific. Using the SC5 mouse cellular model, analysis confirmed that the effect of TNF-α is conserved on muscle-specific miRNAs across species.

    From this work, the Sirion researchers concluded that TNF-α specifically acts on muscle-specific microRNA expression and that inhibition of muscle-specific microRNA expression is a potential disease mechanism in dystrophic muscle. 

    The group aims to further study the effects of cytokines/growth factors on microRNA expression, develop a functional analysis for regulated microRNAs, and intervene therapeutically on disregulated microRNA in muscle tissue to rescue non-fusion phenotype in vitro by microRNA over-expression. Finally, Dr. Thirion hopes to proceed to proof-of concept in an animal model for muscular dystrophy.

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Easing Restrictions for Terminal Patients

Should the Federal Government Pass a “Right to Try” Bill Allowing Terminally Ill Patients Access to Experimental Medicines?

More »